JPRN-UMIN000002318未知4 期
Effect of ezetimibe/statin combination therapy in patients with type 2 diabetes and dyslipidemia on remnant and inflammation - Ezetimibe/statin combination therapy in patients with type 2 diabetes
Kobe University Graduate School of Medicine, Division of Diabetes, Metabolism and Endocrinology0 个研究点目标入组 100 人开始时间: 2009年8月11日最近更新:
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)During pregnancy or lactation 2)Patients who had allergy to ezetimibe 3)Serious liver or renal diseases 4)Acute or chronic inflammatory diseases 5)Other conditions precluding participation as judged by the investigator
研究者
相似试验
已完成
不适用
Effect of coadministration of ezetimibe with statin therapy versus statin therapy alone on flow mediated vasodilation in patients with coronary artery diseaseISRCTN34110682Johannes Gutenberg-University Mainz (Germany)58
已完成
不适用
Combination therapy with Ezetimibe and Gemfibrozile on post-prandial hypertriglyceridemiaDiabetes.Non-insulin-dependent diabetes mellitusIRCT201105311179N5Zanjan Metabolic Research Center, Zanjan University of medical science90
已完成
不适用
therapeutic efficacy of ezetimibe and statins for vascular endothelial dysfunction by high-fat diet loadingin patients with type 2 diabetesType 2 diabetes HyperlipidemiaJPRN-UMIN000018629niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine20
已完成
不适用
Recognized Effect of Statin and Ezetimibe therapy for achievement LDL-C Goaltype 2 diabetes mellitusJPRN-UMIN000002593Clinical study group for diabetes and dyslipidemia120
招募中
不适用
Effects of ezetimibe combination therapy for patients with atherosclerotic cardiovascular disease; randomized comparison of LDL-cholesterol targeting <70 versus <55mg/dL; Ez-PAVE trialDiseases of the circulatory systemKCT0005547Yonsei University Health System, Severance Hospital3,048